Adding formoterol to budesonide in moderate asthma—health economic results from the FACET study

This publication has 10 references indexed in Scilit:

• Health Economic Guidelines—Similarities, Differences and Some Implications
  Value in Health, 2001
• Prescribing patterns for asthma by general practitioners in six European countries
  Respiratory Medicine, 2000
• Risk factors and costs associated with an asthma attack
  Thorax, 2000
• Exacerbations of Asthma
  American Journal of Respiratory and Critical Care Medicine, 1999
• Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma
  PharmacoEconomics, 1998
• Dose Response to Inhaled Corticosteroids: Benefits and Risks
  Seminars in Respiratory and Critical Care Medicine, 1998
• The Role of Cost-Consequence Analysis in Healthcare Decision-Making
  PharmacoEconomics, 1998
• Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
  New England Journal of Medicine, 1997
• The Use of Consensus Methods and Expert Panels in Pharmacoeconomic Studies
  PharmacoEconomics, 1997
• Statistical analysis of cost outcomes in a randomized controlled clinical trial
  Health Economics, 1994